Showing 1 - 2 results of 2 for search '"Tyrosine kinase inhibitor (TKI)"', query time: 0.04s Refine Results
  1. 1
    An open-label study to determine the maximum tolerated dose of oral ESK-440 administered as a single agent in patients with advanced or metastatic solid tumors

    An open-label study to determine the maximum tolerated dose of oral ESK-440 administered as a single agent in patients with advanced or metastatic solid tumors by Russell J. Schilder, Drew Rasco, Manish R. Sharma

    Published 2025-03-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Long term efficacy and safety of Lorlatinib in ALK-positive non-small cell lung cancer: A case report

    Long term efficacy and safety of Lorlatinib in ALK-positive non-small cell lung cancer: A case report by Jialin Qian, Tianqing Chu

    Published 2025-03-01
    Subjects:
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: